Discover 1,691 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,691
FeaturedActive & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
for
Sleep Apnea, Obstructive, Obesity, Overweight
Location: Shreveport LA, Aurora CO
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07369011
Phase 3, Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes Who Take Daily Insulin
Location: Morehead City NC, Suffolk VA, New Bern NC, Annapolis MD,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes and an A1C Between 7% and 10.5%
for
Diabetes Mellitus, Type 2
Location: New Bedford MA, Bridgeport CT, Brooklyn NY,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Obstructive Sleep Apnea Studies for Adults With a BMI of 27+ Who Could Not Tolerate CPAP
for
Sleep Apnea, Obstructive
Location: Potomac MD, Bradenton FL, Anderson SC, Shreveport LA,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes Taking Only Metformin or No Diabetes Medicine
for
Diabetes Mellitus, Type 2
Location: Bridgeport CT, Brooklyn NY, Newport News VA, Bowie MD,
Sex: All
Age: 18+
Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Durham NC,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
Risk Factors in Early Multiple Sclerosis
for
Multiple Sclerosis, Magnetic Resonance Imaging, Biomarkers,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 30
Code: NCT03586986
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans
for
Overweight/Obesity, Stress
Location: Aurora CO
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT06627569
Recruiting
Active & Responsive
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase
for
Anxiety Disorders
Location: Denver CO
Sponsor: University of Denver
Sex: All
Age: 10 - 17
Code: NCT07818876
Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: New Haven CT, New York NY, Albany NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase 3, Recruiting
Active & Responsive
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Location: Boston MA, New Brunswick NJ, Hershey PA, Akron OH,
Sponsor: Anagram Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07450547
Phase 2, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, New Brunswick NJ, Greenville NC,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer